Regulation of beta-cell mass by hormones and growth factors.

PubWeight™: 1.46‹?› | Rank: Top 5%

🔗 View Article (PMID 11272193)

Published in Diabetes on February 01, 2001

Authors

J H Nielsen1, E D Galsgaard, A Møldrup, B N Friedrichsen, N Billestrup, J A Hansen, Y C Lee, C Carlsson

Author Affiliations

1: Department of Cell Biology, Hagedorn Research Institute, Gentofte, Denmark. jhn@imbg.ku.dk

Articles citing this

The diabetes-linked transcription factor PAX4 promotes {beta}-cell proliferation and survival in rat and human islets. J Cell Biol (2004) 1.64

Beta-cell failure as a complication of diabetes. Rev Endocr Metab Disord (2008) 1.60

Insulin and insulin resistance. Clin Biochem Rev (2005) 1.57

Gestational diabetes mellitus resulting from impaired beta-cell compensation in the absence of FoxM1, a novel downstream effector of placental lactogen. Diabetes (2009) 1.47

mTORC1 activation regulates beta-cell mass and proliferation by modulation of cyclin D2 synthesis and stability. J Biol Chem (2009) 1.24

Insulin-producing cells generated from dedifferentiated human pancreatic beta cells expanded in vitro. PLoS One (2011) 1.23

Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. Curr Diabetes Rev (2013) 1.21

Ras-GRF1 signaling is required for normal beta-cell development and glucose homeostasis. EMBO J (2003) 1.21

ICA512 signaling enhances pancreatic beta-cell proliferation by regulating cyclins D through STATs. Proc Natl Acad Sci U S A (2008) 1.20

Fission of pancreatic islets during postnatal growth of the mouse. J Anat (2004) 1.13

Nuclear translocation of an ICA512 cytosolic fragment couples granule exocytosis and insulin expression in {beta}-cells. J Cell Biol (2004) 1.12

Blood glucose levels regulate pancreatic beta-cell proliferation during experimentally-induced and spontaneous autoimmune diabetes in mice. PLoS One (2009) 1.11

Glial cell line-derived neurotrophic factor increases beta-cell mass and improves glucose tolerance. Gastroenterology (2008) 0.98

Id3 upregulates BrdU incorporation associated with a DNA damage response, not replication, in human pancreatic β-cells. Islets (2011) 0.94

The transcription factors Stat5a/b are not required for islet development but modulate pancreatic beta-cell physiology upon aging. Biochim Biophys Acta (2007) 0.93

Differential expression of glucagon and glucagon-like peptide 1 receptors in mouse pancreatic alpha and beta cells in two models of alpha cell hyperplasia. Mol Cell Endocrinol (2009) 0.92

Loss of Foxd3 results in decreased β-cell proliferation and glucose intolerance during pregnancy. Endocrinology (2011) 0.87

APG: an Active Protein-Gene network model to quantify regulatory signals in complex biological systems. Sci Rep (2013) 0.86

Single-Cell Mass Cytometry Analysis of the Human Endocrine Pancreas. Cell Metab (2016) 0.85

Ex-vivo Expansion of Adult Human Pancreatic Beta-Cells. Rev Diabet Stud (2008) 0.84

Signaling cross talk between growth hormone (GH) and insulin-like growth factor-I (IGF-I) in pancreatic islet β-cells. Mol Endocrinol (2011) 0.83

Beneficial effects of growth hormone-releasing hormone agonists on rat INS-1 cells and on streptozotocin-induced NOD/SCID mice. Proc Natl Acad Sci U S A (2015) 0.82

Fetal pancreas transplants are dependent on prolactin for their development and prevent type 1 diabetes in syngeneic but not allogeneic mice. Diabetes (2013) 0.81

A simple matter of life and death-the trials of postnatal Beta-cell mass regulation. Int J Endocrinol (2012) 0.81

Pancreatic expression and mitochondrial localization of the progestin-adipoQ receptor PAQR10. Mol Med (2008) 0.80

Current status of regeneration of pancreatic β-cells. J Diabetes Investig (2013) 0.79

Mechanistic insights into pancreatic beta-cell mass regulation by glucose and free fatty acids. Anat Cell Biol (2015) 0.79

Lack of Wdr13 gene in mice leads to enhanced pancreatic beta cell proliferation, hyperinsulinemia and mild obesity. PLoS One (2012) 0.79

Tissue-Specific GHR Knockout Mice: Metabolic Phenotypes. Front Endocrinol (Lausanne) (2015) 0.78

CCAAT-enhancer-binding protein β (C/EBPβ) and downstream human placental growth hormone genes are targets for dysregulation in pregnancies complicated by maternal obesity. J Biol Chem (2013) 0.78

Beta Cell Mass Restoration in Alloxan-Diabetic Mice Treated with EGF and Gastrin. PLoS One (2015) 0.78

Re-expression of IGF-II is important for beta cell regeneration in adult mice. PLoS One (2012) 0.77

ISL-1 promotes pancreatic islet cell proliferation by forming an ISL-1/Set7/9/PDX-1 complex. Cell Cycle (2015) 0.77

Using growth hormone levels to detect macroadenoma in patients with acromegaly. Endocrinol Metab (Seoul) (2014) 0.76

The ability of β-cells to compensate for insulin resistance is restored with a reduction in excess growth hormone in Korean acromegalic patients. J Korean Med Sci (2012) 0.76

Glucose regulates rat beta cell number through age-dependent effects on beta cell survival and proliferation. PLoS One (2014) 0.75

Loss of Free Fatty Acid Receptor 2 leads to impaired islet mass and beta cell survival. Sci Rep (2016) 0.75

Suppressors of Cytokine Signaling in Sickness and in Health of Pancreatic β-Cells. Front Immunol (2016) 0.75

STAT3 modulates β-cell cycling in injured mouse pancreas and protects against DNA damage. Cell Death Dis (2016) 0.75

Correlation Between Glycated Hemoglobin and Homa Indices in Type 2 Diabetes Mellitus: Prediction of Beta-Cell Function from Glycated Hemoglobin. J Med Biochem (2015) 0.75

Use of additives, scaffolds and extracellular matrix components for improvement of human pancreatic islet outcomes in vitro: A systematic review. Islets (2017) 0.75

Articles by these authors

Receptor-mediated pinocytosis of mannose glycoconjugates by macrophages: characterization and evidence for receptor recycling. Cell (1980) 5.95

Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med (2001) 3.98

Definition of a common leukocyte cell-surface antigen (Lp95-150) associated with diverse cell-mediated immune functions. J Immunol (1983) 3.70

Proliferation of sorted human and rat beta cells. Diabetologia (2007) 3.56

Foreign body aspiration into the lower airway in Chinese adults. Chest (1997) 3.54

Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen). J Exp Med (1985) 3.48

Identification of a human T lymphocyte surface protein associated with the E-rosette receptor. J Exp Med (1981) 3.06

Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood (1998) 3.06

Monosaccharide analysis of glycoconjugates by anion exchange chromatography with pulsed amperometric detection. Anal Biochem (1988) 3.01

Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A (1990) 2.88

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med (1993) 2.85

Mannose receptor-mediated regulation of serum glycoprotein homeostasis. Science (2002) 2.75

Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J Exp Med (1993) 2.71

Epidural hematoma associated with epidural anesthesia: complications of anticoagulant therapy. Anesthesiology (1992) 2.64

Cell surface antigens of human melanoma identified by monoclonal antibody. Proc Natl Acad Sci U S A (1979) 2.40

A single-injection, multi-segmental paravertebral block-extension of somatosensory and sympathetic block in volunteers. Acta Anaesthesiol Scand (2001) 2.30

2-Imino-2-methoxyethyl 1-thioglycosides: new reagents for attaching sugars to proteins. Biochemistry (1976) 2.18

Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells. J Natl Cancer Inst (2001) 2.17

Monoclonal antibody analysis of human T lymphocyte subpopulations exhibiting autologous mixed lymphocyte reaction. Proc Natl Acad Sci U S A (1981) 2.16

The events of primary T cell activation can be staged by use of Sepharose-bound anti-T3 (64.1) monoclonal antibody and purified interleukin 1. J Immunol (1985) 2.14

Identification and functional characterization of two distinct epitopes on the human T cell surface protein Tp50. J Immunol (1983) 2.13

The ileal brake--inhibition of jejunal motility after ileal fat perfusion in man. Gut (1984) 2.11

Allergic rhinitis and risk of erectile dysfunction--a nationwide population-based study. Allergy (2013) 2.04

Prospective study of drug reporting by general practitioners for an elderly population referred to a geriatric service. Br Med J (Clin Res Ed) (1987) 2.02

Heart-synchronized ventilation during general anesthesia for extracorporeal shock wave lithotripsy. Anesth Analg (1988) 2.01

Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood (1994) 1.98

A 44 kilodalton cell surface homodimer regulates interleukin 2 production by activated human T lymphocytes. J Immunol (1986) 1.95

L-Fucose-terminated glycoconjugates are recognized by pinocytosis receptors on macrophages. Proc Natl Acad Sci U S A (1981) 1.93

A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo. J Biol Chem (1999) 1.92

Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med (1993) 1.92

Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol (1990) 1.91

Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. N Engl J Med (1983) 1.89

Nomenclature for factors of the HLA system, 2002. Tissue Antigens (2002) 1.89

Antibody binding to CD5 (Tp67) and Tp44 T cell surface molecules: effects on cyclic nucleotides, cytoplasmic free calcium, and cAMP-mediated suppression. J Immunol (1986) 1.89

Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood (1985) 1.81

Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood (1997) 1.80

Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling. J Biol Chem (1998) 1.79

The synthesis of 4-methylumbelliferyl alpha-ketoside of N-acetylneuraminic acid and its use in a fluorometric assay for neuraminidase. Anal Biochem (1980) 1.78

Hereditary C2 deficiency: Genetic studies and association with the HL-A system. J Exp Med (1975) 1.75

Detection of maternal cells in human umbilical cord blood using fluorescence in situ hybridization. Blood (1995) 1.75

Pulmonary pleomorphic (spindle) cell carcinoma: peculiar clinicopathologic manifestations different from ordinary non-small cell carcinoma. Lung Cancer (2001) 1.73

Alloantigen-specific cytotoxic and suppressor T lymphocytes are derived from phenotypically distinct precursors. J Immunol (1983) 1.73

Binding of synthetic oligosaccharides to the hepatic Gal/GalNAc lectin. Dependence on fine structural features. J Biol Chem (1983) 1.72

Affinity enhancement by multivalent lectin-carbohydrate interaction. Glycoconj J (2001) 1.72

Rapid screening of T-cell receptor (TCR) variable gene usage by multiplex PCR: application for assessment of clonal composition. Tissue Antigens (1999) 1.71

The structural and functional organization of the yeast mediator complex. J Biol Chem (2001) 1.71

Chitin utilization by marine bacteria. Degradation and catabolism of chitin oligosaccharides by Vibrio furnissii. J Biol Chem (1991) 1.70

Specific genomic markers for the HLA-DQ subregion discriminate between DR4+ insulin-dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis. J Exp Med (1986) 1.69

Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers. Blood (1995) 1.68

Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood (1997) 1.65

Bombesin: action on gut hormones and calcium in man. J Clin Endocrinol Metab (1982) 1.65

Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation. Blood (1997) 1.64

Fecundity before disease onset in women with rheumatoid arthritis. Arthritis Rheum (1993) 1.64

The molecular basis for HLA class II associations with rheumatoid arthritis. J Clin Immunol (1987) 1.64

Surgical treatment for pulmonary aspergilloma: a 28 year experience. Thorax (1997) 1.63

Absence of monoclonal-antibody-defined protein complex in boy with abnormal leucocyte function. Lancet (1984) 1.63

Adhesion of hepatocytes to immobilized sugars. A threshold phenomenon. J Biol Chem (1979) 1.61

Effects on the child of alcohol abuse during pregnancy. Retrospective and prospective studies. Acta Paediatr Scand Suppl (1979) 1.60

In vivo requirement of activator-specific binding targets of mediator. Mol Cell Biol (2000) 1.58

Nomenclature for factors of the HLA system, 2004. Tissue Antigens (2005) 1.57

Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood (1997) 1.57

Linkage between the gene (or genes) controlling synthesis of the fourth component of complement and the major histocompatibility complex. N Engl J Med (1977) 1.55

NHLBI workshop summary. Idiopathic pneumonia syndrome after bone marrow transplantation. Am Rev Respir Dis (1993) 1.54

Distinct patterns of transmembrane calcium flux and intracellular calcium mobilization after differentiation antigen cluster 2 (E rosette receptor) or 3 (T3) stimulation of human lymphocytes. J Clin Invest (1986) 1.53

Seroepidemiological study of Helicobacter pylori infection in asymptomatic people in South Korea. J Gastroenterol Hepatol (2001) 1.53

Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation. J Immunol (1986) 1.52

Longitudinal patterns of analgesic and central acting drug use and associated effectiveness in fibromyalgia. Eur J Pain (2012) 1.52

The HLA-DR4 family of haplotypes consists of series of distinct DR and DS molecules. J Exp Med (1984) 1.51

Monoclonal antibody 9.3 and anti-CD11 antibodies define reciprocal subsets of lymphocytes. Eur J Immunol (1985) 1.51

Is minimal change esophagitis really part of the spectrum of endoscopic findings of gastroesophageal reflux disease? A prospective, multicenter study. Endoscopy (2011) 1.51

Five years results of photorefractive keratectomy for myopia. J Cataract Refract Surg (1997) 1.51

Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer. J Clin Oncol (2001) 1.50

Dw14(DRB1*0404) is a Dw4-dependent risk factor for rheumatoid arthritis. Rethinking the "shared epitope" hypothesis. Tissue Antigens (1991) 1.50

Narrow-band imaging with magnifying endoscopy for the screening of esophageal cancer in patients with primary head and neck cancers. Endoscopy (2010) 1.50

Rheumatoid factor, HLA-DR4, and allelic variants of DRB1 in women with recent-onset rheumatoid arthritis. Arthritis Rheum (1994) 1.49

An activity in rat tissues that modifies nitrotyrosine-containing proteins. Proc Natl Acad Sci U S A (1998) 1.49

Needle aspiration biopsy of malignant lung masses with necrotic centers. Improved sensitivity with ultrasonic guidance. Chest (1993) 1.48

Binding of microtubules to pituitary secretory granules and secretory granule membranes. J Cell Biol (1977) 1.46

In vitro regulation of immunoglobulin synthesis by T-cell subpopulations defined by a new human T-cell antigen (9.3). Cell Immunol (1982) 1.46

Inheritable variable sizes of DNA stretches in the human MHC: conserved extended haplotypes and their fragments or blocks. Tissue Antigens (2003) 1.46

Activator-specific requirement of yeast mediator proteins for RNA polymerase II transcriptional activation. Mol Cell Biol (1999) 1.44

Growth arrest specific protein (GAS) 6: a role in the regulation of proliferation and functional capacity of the perinatal rat beta cell. Diabetologia (2013) 1.44

Silencing mediator of retinoic acid and thyroid hormone receptors, as a novel transcriptional corepressor molecule of activating protein-1, nuclear factor-kappaB, and serum response factor. J Biol Chem (2000) 1.43

A new human T-cell differentiation antigen: unexpected expression on chronic lymphocytic leukemia cells. Immunogenetics (1980) 1.43

Determination of nucleotides and sugar nucleotides involved in protein glycosylation by high-performance anion-exchange chromatography: sugar nucleotide contents in cultured insect cells and mammalian cells. Anal Biochem (2001) 1.42

The in vitro polymerization of tubulin from beef brain. J Neurobiol (1974) 1.42

Sensory and motor dysfunction assessed by anorectal manometry in uterine cervical carcinoma patients with radiation-induced late rectal complication. Int J Radiat Oncol Biol Phys (1998) 1.42

Induction of calcium flux and enhancement of cytolytic activity in natural killer cells by cross-linking of the sheep erythrocyte binding protein (CD2) and the Fc-receptor (CD16). J Immunol (1987) 1.42

Attachment of thioglycosides to proteins: enhancement of liver membrane binding. Biochemistry (1976) 1.41

Monoclonal antibodies recognizing normal human T lymphocytes and malignant human B lymphocytes: a comparative study. J Immunol (1981) 1.41

Use of esophagectomy to treat recurrent hyperplastic tissue obstruction caused by multiple metallic stent insertion for corrosive stricture. Endoscopy (2000) 1.41

Mixed lymphocyte culture determinants and C2 deficiency: LD-7a associated with C2 deficiency in four families. J Exp Med (1975) 1.40

Electrophoretic analysis of human HLA-DR antigens from HLA-DR4 homozygous cell lines: correlation between beta-chain diversity and HLA-D. Proc Natl Acad Sci U S A (1983) 1.40

Fluorometric assay for measurement of viral neuraminidase--application to the rapid detection of influenza virus in nasal wash specimens. J Infect Dis (1980) 1.40

Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia. Bone Marrow Transplant (1992) 1.40

Nomenclature for factors of the HLA system, 1998. Tissue Antigens (1999) 1.40

Fine structure of a cerebellar neuroblastoma. Acta Neuropathol (1978) 1.40

Specific cell adhesion to immobilized glycoproteins demonstrated using new reagents for protein and glycoprotein immobilization. J Biol Chem (1983) 1.39

T-cell subpopulations identified by monoclonal antibodies after human marrow transplantation. I. Helper-inducer and cytotoxic-suppressor subsets. Blood (1982) 1.39